FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308773887> ?p ?o ?g. }

• W4308773887 endingPage "773" @default.
• W4308773887 startingPage "762" @default.
• W4308773887 abstract "Isavuconazole has theoretical advantages over other mold-active triazoles for the treatment of invasive aspergillosis and mucormycosis after solid organ transplantation (SOT). The available clinical experience, nevertheless, is scarce.We performed a retrospective study including all adult SOT recipients with proven or probable invasive mold disease (IMD) that received isavuconazole for ≥24 h as first-line or salvage therapy at 10 Spanish centers between September 2017 and November 2021. The primary efficacy outcome was clinical response (complete or partial resolution of attributable symptoms and findings) by weeks 6 and 12. Safety outcomes included the rates of treatment-emergent adverse events and premature isavuconazole discontinuation.We included 81 SOT recipients that received isavuconazole for a median of 58.0 days because of invasive aspergillosis (n = 71) or mucormycosis (n = 10). Isavuconazole was used as first-line (72.8%) or salvage therapy due because of previous treatment-emergent toxicity (11.1%) or refractory IMD (7.4%). Combination therapy was common (37.0%), mainly with an echinocandin or liposomal amphotericin B. Clinical response by weeks 6 and 12 was achieved in 53.1% and 54.3% of patients, respectively, and was more likely when isavuconazole was administered as first-line single-agent therapy. At least 1 treatment-emergent adverse event occurred in 17.3% of patients, and 6.2% required premature discontinuation. Daily tacrolimus dose was reduced in two-thirds of patients by a median of 50.0%, although tacrolimus levels remained stable throughout the first month of therapy.Isavuconazole is a safe therapeutic option for IMD in SOT recipients, with efficacy comparable to other patient groups." @default.
• W4308773887 created "2022-11-15" @default.
• W4308773887 creator A5008546249 @default.
• W4308773887 creator A5009198871 @default.
• W4308773887 creator A5016173324 @default.
• W4308773887 creator A5016258231 @default.
• W4308773887 creator A5021918368 @default.
• W4308773887 creator A5034497277 @default.
• W4308773887 creator A5037925029 @default.
• W4308773887 creator A5038511760 @default.
• W4308773887 creator A5039813934 @default.
• W4308773887 creator A5045118610 @default.
• W4308773887 creator A5048315302 @default.
• W4308773887 creator A5050159426 @default.
• W4308773887 creator A5062363608 @default.
• W4308773887 creator A5071487615 @default.
• W4308773887 creator A5077820216 @default.
• W4308773887 creator A5078928599 @default.
• W4308773887 creator A5079680193 @default.
• W4308773887 creator A5081530193 @default.
• W4308773887 creator A5082595239 @default.
• W4308773887 creator A5082894673 @default.
• W4308773887 date "2022-10-20" @default.
• W4308773887 modified "2023-10-16" @default.
• W4308773887 title "Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice" @default.
• W4308773887 cites W1785850987 @default.
• W4308773887 cites W1839799574 @default.
• W4308773887 cites W1930554712 @default.
• W4308773887 cites W2031785695 @default.
• W4308773887 cites W2068279177 @default.
• W4308773887 cites W2082695689 @default.
• W4308773887 cites W2105860549 @default.
• W4308773887 cites W2122561192 @default.
• W4308773887 cites W2144677985 @default.
• W4308773887 cites W2189861011 @default.
• W4308773887 cites W2284948484 @default.
• W4308773887 cites W2294786018 @default.
• W4308773887 cites W2296337564 @default.
• W4308773887 cites W2339376601 @default.
• W4308773887 cites W2415618052 @default.
• W4308773887 cites W2461860618 @default.
• W4308773887 cites W2470291098 @default.
• W4308773887 cites W2524405324 @default.
• W4308773887 cites W2732950461 @default.
• W4308773887 cites W2737245802 @default.
• W4308773887 cites W2754311586 @default.
• W4308773887 cites W2762058653 @default.
• W4308773887 cites W2793884909 @default.
• W4308773887 cites W2800735060 @default.
• W4308773887 cites W2809760546 @default.
• W4308773887 cites W2894846186 @default.
• W4308773887 cites W2921407021 @default.
• W4308773887 cites W2924814601 @default.
• W4308773887 cites W2940809162 @default.
• W4308773887 cites W2953587523 @default.
• W4308773887 cites W2981290341 @default.
• W4308773887 cites W2990725098 @default.
• W4308773887 cites W2992250822 @default.
• W4308773887 cites W3034139771 @default.
• W4308773887 cites W3112984291 @default.
• W4308773887 cites W3157149472 @default.
• W4308773887 cites W3179792382 @default.
• W4308773887 cites W3196277368 @default.
• W4308773887 cites W3208016826 @default.
• W4308773887 cites W4200492074 @default.
• W4308773887 cites W4205130088 @default.
• W4308773887 cites W4213194472 @default.
• W4308773887 doi "https://doi.org/10.1097/tp.0000000000004312" @default.
• W4308773887 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36367924" @default.
• W4308773887 hasPublicationYear "2022" @default.
• W4308773887 type Work @default.
• W4308773887 citedByCount "2" @default.
• W4308773887 countsByYear W43087738872023 @default.
• W4308773887 crossrefType "journal-article" @default.
• W4308773887 hasAuthorship W4308773887A5008546249 @default.
• W4308773887 hasAuthorship W4308773887A5009198871 @default.
• W4308773887 hasAuthorship W4308773887A5016173324 @default.
• W4308773887 hasAuthorship W4308773887A5016258231 @default.
• W4308773887 hasAuthorship W4308773887A5021918368 @default.
• W4308773887 hasAuthorship W4308773887A5034497277 @default.
• W4308773887 hasAuthorship W4308773887A5037925029 @default.
• W4308773887 hasAuthorship W4308773887A5038511760 @default.
• W4308773887 hasAuthorship W4308773887A5039813934 @default.
• W4308773887 hasAuthorship W4308773887A5045118610 @default.
• W4308773887 hasAuthorship W4308773887A5048315302 @default.
• W4308773887 hasAuthorship W4308773887A5050159426 @default.
• W4308773887 hasAuthorship W4308773887A5062363608 @default.
• W4308773887 hasAuthorship W4308773887A5071487615 @default.
• W4308773887 hasAuthorship W4308773887A5077820216 @default.
• W4308773887 hasAuthorship W4308773887A5078928599 @default.
• W4308773887 hasAuthorship W4308773887A5079680193 @default.
• W4308773887 hasAuthorship W4308773887A5081530193 @default.
• W4308773887 hasAuthorship W4308773887A5082595239 @default.
• W4308773887 hasAuthorship W4308773887A5082894673 @default.
• W4308773887 hasConcept C121332964 @default.
• W4308773887 hasConcept C126322002 @default.
• W4308773887 hasConcept C141071460 @default.
• W4308773887 hasConcept C142424586 @default.

• next